May 4, 2009
Update
In great news to start off the week, Congressional Quarterly’s Kathleen Hunter is reporting that Senator Charles Grassley will likely hold onto his position on the US Senate Finance Committee until 2011.
“Grassley said last week that he preferred to remain as the top Republican on the Finance panel for the remainder of the 111th Congress but might reconsider if something was “going to happen in the interim” that would keep him from taking over the top Judiciary post in 2011,” she wrote.
“Alabama Sen. Jeff Sessions will take over the top Republican spot on the Judiciary Committee for the remainder of the 111th Congress and then yield to Charles E. Grassley of Iowa in 2011, under a deal reached between the two, a senior GOP aide confirmed Monday,” Hunter reports.
This news has to be a big let down for Big Pharma and all the hangers-on whose financial dealings with drug and device companies have come under the microscope through Grassley’s relentless investigations.
Thank God! We finally have a senator who is looking into the corruption, fraud, and conflict-of-interest that has taken over the pharmaceutical industry and FDA, only to hear rumors that he might step down! I hope he takes down pHARMa and the FDA a couple of notches during his time left on the committee.
[…] letters to Senators Charles Grassley and Herb Kohl, and Representatives Henry Waxman, Bart Stupak, John Dingell and Barney Frank, on May […]
Good information once again! Thanks!/21.03.2011 04:47:39